The practical and legal difficulties of breaking into the Chinese market. Recent developments in clinical trials, regulatory framework, classification, device registration, and the NMPA Legal Agent were among the important subjects covered. There was also discussion of best practices and linguistic issues for compliance, with SeproTec and Cisema experts offering advice on navigating the Chinese medical device market.
